result
neurolog
examin
normal
strength
proxim
distal
muscl
group
resolv
wast
normal
reflex
sensat
continu
normal
last
followup
year
initi
hospit
admiss
asymptomat
without
recurr
hypernephroma
medic
literatur
motor
neuronopathi
rare
associ
solid
tumor
recent
review
forsyth
et
al
describ
patient
motor
neuron
diseas
cancer
group
patient
antihu
antibodi
patient
either
lower
motor
neuron
lmn
upper
motor
neuron
umn
form
patient
typic
combin
umn
lmn
find
author
suggest
patient
either
specif
paraneoplast
marker
eg
antihu
isol
umn
lmn
syndrom
investig
underli
cancer
seri
one
patient
small
cell
lung
cancer
improv
muscular
weak
chemotherapi
earli
clinic
cours
two
patient
develop
respiratori
failur
late
diseas
cours
requir
mechan
ventil
patient
present
respiratori
failur
abl
wean
mechan
ventil
therapi
tumor
knowledg
first
report
case
paraneoplast
motor
neuron
diseas
mnd
present
respiratori
failur
furthermor
complet
recoveri
motor
strength
success
wean
ventil
support
follow
remov
underli
malign
case
report
patient
mnd
remiss
neurolog
symptom
success
remov
tumor
renal
cell
carcinoma
associ
mnd
report
present
typic
peripher
motor
weak
resolut
improv
symptom
follow
remov
renal
tumor
case
presum
autoantibodi
relat
resolut
antibodi
product
tumor
remov
patient
unexplain
neuromuscular
respiratori
failur
differenti
diagnosi
includ
revers
paraneoplast
motor
neuronopathi
neurolog
investig
emgnerv
conduct
studi
sought
earli
patient
infecti
bronchiti
viru
otherwis
known
coronaviru
caus
mild
upper
respiratori
tract
ill
children
adult
rare
coronaviru
link
either
serolog
nasal
wash
pneumonia
report
case
young
woman
follow
treatment
stage
iiia
breast
cancer
use
highdos
chemotherapi
regimen
follow
autolog
bone
marrow
stem
cell
transplant
develop
respiratori
failur
found
coronaviru
pneumonia
diagnos
electron
microscopi
bal
fluid
propos
coronaviru
consid
differenti
diagnosi
acut
respiratori
failur
cancer
patient
undergon
highdos
chemotherapi
autolog
hematopoiet
support
remain
case
infecti
agent
could
identifi
sever
distinct
syndrom
describ
idiopath
pneumonia
syndrom
ip
sever
form
posttranspl
interstiti
pneumon
best
character
sever
hypoxemia
radiograph
infiltr
associ
high
mortal
howev
recent
describ
detail
milder
form
posttranspl
pneumon
occur
autolog
bone
marrow
transplant
bmt
patient
term
delay
pulmonari
toxic
syndrom
dpt
dpt
character
high
incid
prompt
respons
steroid
resolut
pulmonari
symptom
improv
diffus
carbon
monoxid
dlco
low
mortal
radiograph
abnorm
present
typic
appear
scatter
predominantli
peripher
illdefin
opac
possibl
mechan
pathogenesi
either
ip
dpt
includ
follow
pulmonari
drug
toxic
reaction
caus
carmustin
bcnu
andor
cyclophosphamid
imbal
lung
cytokin
promot
proinflammatori
state
occult
latent
viral
infect
eg
cmv
rsv
epsteinbarr
viru
human
herp
viru
imbal
pulmonari
oxid
antioxid
allogen
transplant
patient
contrast
autolog
also
suscept
graftvshost
diseas
process
addit
maintain
immunodefici
state
extend
time
coronavirus
one
recent
identifi
major
famili
virus
associ
develop
common
cold
famili
positivesens
singlestrand
rna
virus
distinct
clubshap
project
impart
crown
coronashap
appear
two
major
serolog
coronaviru
strain
identifi
import
human
diseas
indirectli
coronaviru
link
lower
respiratori
tract
infect
report
document
develop
acut
respiratori
failur
follow
bmt
atyp
either
ip
dpt
believ
caus
exacerb
coronaviru
pneumonia
knowledg
repres
first
report
case
coronaviru
isol
lower
respiratori
tract
specimen
adult
pneumonia
jamaican
woman
day
post
hdcabmt
stage
iiia
breast
carcinoma
admit
duke
univers
hospit
complaint
fatigu
anorexia
weight
loss
workup
hyperbilirubinemia
patient
well
month
prior
hospit
admiss
left
breast
mass
note
selfexamin
incision
biopsi
specimen
subsequ
modifi
radic
mastectomi
reveal
infiltr
ductal
carcinoma
lymph
node
posit
metastat
tumor
stage
chest
abdomenpelvishead
ct
bone
scan
reveal
metastat
diseas
result
initi
laboratori
studi
includ
liver
function
test
normal
baselin
pulmonari
function
test
demonstr
fev
ls
fvc
l
total
lung
capac
l
hemoglobincorrect
dlco
mlminmm
hg
patient
enrol
cancer
leukemia
group
b
protocol
receiv
four
cycl
caf
cyclophosphamid
mgm
day
doxorubicin
mgm
day
fluorouracil
mgm
day
given
everi
day
fig
follow
highdos
cpacddpbcnu
cyclophosphamid
mgm
given
iv
h
three
consecut
day
day
cisplatin
mgm
given
continu
infus
h
day
day
bcnu
mgm
infus
h
day
total
plasma
area
curv
cyclophosphamid
gml
min
cisplatin
level
determin
end
dose
ngml
bcnu
plasma
area
curv
gml
min
two
day
follow
highdos
chemotherapi
peripher
blood
progenitor
cell
reinfus
day
autolog
bone
marrow
cell
per
kilogram
bodi
weight
reinfus
day
provid
cellular
support
engraft
unev
occur
week
thirtyeight
day
postbmt
patient
develop
cours
day
nonproduct
cough
dyspnea
arteri
blood
ga
determin
perform
room
air
show
ph
pco
mm
hg
po
mm
hg
satur
pulmonari
function
test
time
show
dlco
fallen
baselin
level
fig
base
find
diagnos
dpt
start
regimen
oral
prednison
mgd
addit
prophylact
oral
trimethoprimsulfamethoxazol
prescrib
respond
prednison
treatment
prompt
resolut
pulmonari
symptom
modest
improv
dlco
day
postbmt
routin
blood
test
demonstr
mildli
elev
result
liver
function
test
day
chest
wall
region
node
radiat
therapi
begun
continu
week
total
dose
gy
day
postbmt
patient
admit
hospit
workup
persist
hyperbilirubinemia
percutan
liver
biopsi
specimen
demonstr
sever
centrilobular
cholestasi
plug
canaliculi
consist
centrilobular
canalicular
hepatocellular
cholestasi
believ
consist
idiosyncrat
drug
reaction
later
even
develop
brief
episod
hypotens
complain
right
shoulder
pain
abdomin
ct
demonstr
small
right
subcapsular
hematoma
site
liver
biopsi
hospit
day
patient
spike
fever
temperatur
blood
urin
cultur
sent
laboratori
patient
start
regimen
oral
clarithromycin
time
complain
sore
throat
new
cough
slightli
product
sputum
nasal
swab
neg
rsv
parainfluenza
b
c
adenoviru
influenza
b
result
pulmonari
function
test
unchang
day
previous
fig
hospit
day
patient
note
tachypn
respiratori
rate
arteri
blood
ga
determin
obtain
room
air
show
ph
pco
po
satur
echocardiogram
demonstr
normal
ventricular
function
despit
diuresi
patient
respiratori
statu
continu
deterior
elect
intub
concern
recurr
dpt
patient
start
regimen
highdos
methylprednisolon
mg
iv
everi
h
erythromycin
sulfamethoxazol
trimethoprim
bactrim
imipenem
ad
empir
portabl
chest
radiograph
chest
ct
scan
demonstr
bilater
predominantli
lower
lobe
air
space
opac
fig
hospit
day
patient
underw
bronchoscopi
bal
lower
lobe
obtain
via
endotrach
tube
microbiolog
examin
demonstr
bal
sampl
neg
fungu
acidfast
bacilli
gram
stain
cultur
cytolog
special
stain
respiratori
viral
batteri
rsv
parainfluenza
b
c
adenoviru
influenza
b
cmv
herp
simplex
viru
cultur
cytolog
analysi
show
rare
atyp
cell
background
highli
reactiv
pneumocyt
electron
microscopi
em
bal
fluid
demonstr
numer
viral
particl
featur
diagnost
coronaviru
fig
hospit
day
treatment
antibiot
stop
patient
complet
defervesc
hospit
day
patient
success
extub
hospit
day
breath
room
air
oxygen
satur
steroid
chang
prednison
mg
taper
week
hospit
day
discharg
home
followup
visit
postbmt
day
show
dlco
decreas
approxim
prehospit
valu
fig
howev
respiratori
statu
remain
asymptomat
incid
pulmonari
toxic
reaction
follow
high
dose
cyclophosphamidecisplatin
bcnu
autolog
bone
marrow
support
duke
univers
bone
marrow
transplant
program
approxim
patient
infect
rule
low
mortal
rate
prompt
respons
prednison
therapi
featur
term
posttranspl
complic
dpt
dpt
contrast
ip
syndrom
character
sever
hypoxemia
radiograph
infiltr
high
mortal
patient
demonstr
three
phase
pulmonari
toxic
reaction
phase
subclin
asymptomat
best
character
decreas
dlco
measur
follow
first
three
cycl
caf
induct
chemotherapi
fig
littl
known
contribut
condit
regimen
play
develop
lung
injuri
phase
ii
occur
follow
hdcabmt
diagnos
dpt
base
time
associ
pulmonari
symptom
decreas
dlco
prompt
respons
corticosteroid
therapi
subsequ
improv
dlco
phase
iii
occur
approxim
day
follow
bmt
patient
develop
acut
respiratori
failur
coronaviru
pneumonia
respons
respiratori
failur
believ
bal
sampl
obtain
h
intub
bronchoscop
place
lumen
endotrach
tube
thu
minim
possibl
nasal
mucosa
contamin
consid
possibl
exampl
coronaviru
could
simpli
present
bal
specimen
pathogen
scenario
etiolog
respiratori
failur
could
caus
sever
differ
factor
includ
radiat
pneumon
druginduc
interstiti
pneumon
shower
lung
inflammatori
cytokin
abdomin
septic
sourc
result
ard
radiat
pneumon
seem
less
like
sinc
pattern
radiograph
lung
injuri
duplic
radiat
port
although
case
studi
shown
radiat
pneumon
occur
outsid
radiat
port
would
unusu
see
interstiti
pneumon
hdcabmt
far
transplant
without
concomit
decreas
dlco
liver
biopsi
occur
day
respiratori
failur
complic
stabl
subcapsular
hematoma
brief
episod
hypotens
fever
exclud
possibl
inflammatori
cytokin
releas
gi
sourc
shower
lung
caus
acut
lung
injuri
lead
respiratori
failur
also
could
rule
bacteri
pneumonia
complic
factor
sinc
patient
receiv
antibiot
h
prior
obtain
bal
fluid
would
predict
lower
diagnost
yield
bacteria
coronaviru
caus
lower
respiratori
tract
infect
anim
strain
coronaviru
appear
virul
human
counterpart
shown
caus
pneumonia
mice
pig
human
experiment
intranas
inocul
coronaviru
volunt
result
typic
coryz
ill
nasal
discharg
notabl
absenc
system
complaint
howev
lower
respiratori
tract
involv
suggest
base
coronaviru
posit
nasal
wash
two
children
pneumonia
coronaviru
seroconvers
adult
pneumonia
treatment
option
upper
respiratori
tract
infect
caus
coronaviru
limit
studi
use
intranas
interferon
intranas
nedocromil
improv
symptom
report
document
coronaviru
pneumonia
complic
autolog
bmt
whether
coronaviru
pneumonia
capabl
caus
respiratori
failur
requir
addit
factor
eg
immunocompromis
host
remain
determin
patient
condit
initi
improv
institut
corticosteroid
longerterm
followup
show
deterior
lung
function
leav
us
wonder
coronaviru
caus
direct
cytopatholog
effect
lower
respiratori
airway
cell
discov
coronaviru
patient
bal
specimen
evalu
em
em
typic
perform
bal
specimen
owe
uncertainti
specif
sensit
well
costbenefit
analys
idiopath
pneumonia
patient
popul
account
larg
proport
posttranspl
complic
elect
use
em
evalu
bal
sampl
howev
routin
use
em
await
result
clinic
trial
although
routin
evalu
coronaviru
consid
differenti
diagnos
respiratori
failur
patient
undergon
highdos
chemotherapi
autolog
bmt
